Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? - Wikidata - awgldk - TriplyDB

Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?

Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?

http://www.wikidata.org/entity/Q36560643

about

Heart failure with preserved ejection fraction: emerging drug strategies Vascular stiffness in insulin resistance and obesity Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet.Fructose and uric acid: is there a role in endothelial function?Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes.Effects of aldosterone on insulin sensitivity and secretion.Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.Mineralocorticoid receptors: an appealing target to treat coronary microvascular dysfunction in diabetes.Impact of DHA on metabolic diseases from womb to tomb.The pathophysiology of hypertension in patients with obesity.Mineralocorticoid receptors modulate vascular endothelial function in human obesity Estrogen and mitochondria function in cardiorenal metabolic syndrome.Autophagy: a housekeeper in cardiorenal metabolic health and disease The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females.Role of habitual physical activity in modulating vascular actions of insulin.Effect of long-term high-fat diet intake on peripheral insulin sensibility, blood pressure, and renal function in female rats Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection.Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging.Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction.Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice Clinical perspectives and fundamental aspects of local cardiovascular and renal Renin-Angiotensin systems.Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.Adding Salt to Meals as a Risk Factor of Type 2 Diabetes Mellitus: A Case-Control Study.New insights into insulin action and resistance in the vasculature.Mineralocorticoid receptor modulators: a patent review (2007 - 2012).Membrane estrogen receptors: their role in blood pressure regulation and cardiovascular disease.Adipokines: novel players in resistant hypertension.Activation of mTOR: a culprit of Alzheimer's disease?

P2860

Q24595118-B6D424CF-4248-44ED-A75F-577DC009D17B Q26796220-34852E4F-AFD2-4F58-8BA8-F55E49DF8B06 Q28081458-6A01A6B4-FAED-4F1F-B589-8A6B03458A43 Q33584753-D0720F50-21E9-4E09-B697-D72D92AF7D0E Q33854358-1C107848-984C-4D8F-BF0D-B2991BD44FCD Q34027687-785D551C-36A4-4E3E-9DB3-7AF1BE49B25E Q34062829-478AE726-808E-4336-9341-7AA777BA9B99 Q34409899-1A1FB1C8-A0DC-4600-9018-7C05446F2D0E Q34614820-C8AEE3DA-DC08-4BCE-AA10-E642B16B68FA Q34762461-B9168CD5-7CE7-4DD6-B341-140B6AD2279F Q34762502-61C030EE-6BF3-445B-918D-E125E4160B5C Q34780650-E086C653-BAD2-4F34-8F9E-5C262E8F63EE Q35021492-0589F197-E9FB-4582-9801-BAEB1316D802 Q35031976-0360912B-8760-495F-B94D-900B97C452A2 Q35054122-C79E4513-B1A0-4B5B-97E5-C58E05002667 Q35112261-483789FA-162C-44CB-975E-383E54BC07FF Q35126105-7EA943D5-1C39-4688-94E2-83E6AFD13A2F Q35135440-C28D4D34-9AF8-4C99-8FA4-90E9D283E67D Q35626544-989019F9-5337-4FDD-BDFE-1B2DF56AD775 Q35738015-3AC79C78-3542-4BB9-92CA-9DA9E48A3991 Q36000073-BF234019-5529-4203-82BB-77638ACB9306 Q36277736-FAD48016-E32F-4A13-B399-D4976B34E1A6 Q36438785-336C351F-46D6-4019-8343-7A6AB9A7AA57 Q36581341-B772D810-2D92-4C6F-9FF2-56451D42557B Q36903395-81A137C2-0D31-4C22-8F21-FDBA08598C5B Q36946065-6DCB69FD-1CB5-4A80-87C0-209CF2A2D06F Q36980756-86AA3B38-AA53-43EF-9F27-06F4ED0999D9 Q37258157-8FC9735E-562C-4F83-A620-8571522365F7 Q37261536-51D677B9-A57C-4772-A76A-21E08BC30DAD Q37277242-56A17D5B-E4FA-47CD-92EC-86FBEECABEBD Q37393027-EDC36364-51C5-453A-A719-3F9D49990B80 Q37550688-FE5444D0-AC66-41A5-AD79-E3645DA2E6A7 Q37592161-59758394-5EE5-4EB8-9E3C-C9BB4F4906B9 Q37624307-4A6E06A5-41F5-4094-80CC-B0E8E2371A5B Q37628455-15703930-670E-4F8D-8156-DD06FAE3F25D Q37707789-92A65A33-BF75-4041-8C8C-811180F4EE16 Q38161538-BB23EC91-67B7-4388-AF7B-C9D25307C59E Q38171692-A48BF4DD-37F3-444D-9AB4-83D61B9B4CF6 Q38245895-996932F1-86BA-4945-98F9-ED302A5CA19B Q38443497-528FF1EA-C2B0-47AF-B9CB-7268EAC21AF4

P2860

Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?

http://www.wikidata.org/entity/Q36560643

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Mineralocorticoid receptor-med ...... etes-related vascular disease?

@ast

Mineralocorticoid receptor-med ...... etes-related vascular disease?

@en

type

label

Mineralocorticoid receptor-med ...... etes-related vascular disease?

@ast

Mineralocorticoid receptor-med ...... etes-related vascular disease?

@en

prefLabel

Mineralocorticoid receptor-med ...... etes-related vascular disease?

@ast

Mineralocorticoid receptor-med ...... etes-related vascular disease?

@en

P1433

Q36560643-09A9244E-B091-4EE8-8D9D-CCD3DADEB180

P1476

Q36560643-EA6792C7-4E58-4F43-B001-9F57F18E7BA3

P2093

Q36560643-216252B8-587B-4923-84EB-8C91014730D3

Q36560643-3F50B749-2EA0-49E6-BC1B-43A4B9ABD33C

Q36560643-5BFE7306-151A-43D6-8625-E47CCF3A556C

Q36560643-973B8CC1-6FCE-4096-9764-4AC85E3CCC44

P275

Q36560643-E07DF08C-CA71-4BEB-AF1F-EF941A7A575B

P2860

Q36560643-0496B164-F7A4-478E-BBE2-71E1F221F036

Q36560643-2569089A-FD65-46BB-866E-DDE4B33BEE30

Q36560643-28731993-9220-4AFC-8C15-C0A12E8BCF2E

Q36560643-2FEC09EB-A9E4-4F4D-A5F7-29580B16927C

Q36560643-304C584B-E116-426D-9188-D582883949A8

Q36560643-327CB26D-0237-41FB-8D0E-314C657BB62A

Q36560643-38764938-A0AB-4BEF-80E2-B8B878DC6C17

Q36560643-45D47ED3-1DB2-4324-8303-91B2F9644AE7

Q36560643-48F6921A-FBFB-4AA3-B64B-7E04C69A8041

Q36560643-494DD286-27BF-4636-9684-017CE182C382

P304

Q36560643-13151AEE-BF0F-418D-8E52-4CA6A68E7A0F

P31

Q36560643-8199FA12-5707-48DD-A50B-CC99B38344DC

Q36560643-EFC9D867-2054-4566-A609-4ED768911969

P356

Q36560643-E94B77C6-E909-4738-A228-1D19DF2CBE82

P407

Q36560643-FAF3D097-72FF-4220-A971-7F614F137831

P433

Q36560643-FD70747E-855B-4043-8D61-29651DCEE560

P478

Q36560643-133230B2-1DE9-4767-8695-B9B3CA4861B1

P5008

Q36560643-58B4EEE5-C20C-4D43-A829-CBA7E0536874

P577

Q36560643-AD8C0A9D-09D4-4940-B9F1-2485CFEBDBC2

P5875

Q36560643-1601512C-94A7-4234-A05B-DED20148B05C

P698

Q36560643-0957C85F-4304-4CCA-93F7-38DA91B2F9A7

P921

Q36560643-19F95D14-A292-4397-8D9B-FF60628C5CA2

Q36560643-5399EAD1-569A-4204-8736-FD6346580668

Q36560643-890CD27D-2697-4564-9375-1982C51B045C

Q36560643-93D94585-BF11-457F-B773-1E733AF1F932

Q36560643-96688F17-0BC5-4360-8B54-58236659B1E3

Q36560643-C9D0134F-8619-4370-A085-367DF6418EDB

Q36560643-D761DBD2-B7A3-4677-9034-95A6FF586BD8

P932

Q36560643-9056C73C-E376-4AA9-B460-708E87126842

P356

P1433

P1476

Mineralocorticoid receptor-med ...... etes-related vascular disease?

@en

P2093

Adam P McGraw

http://www.w3.org/2001/XMLSchema#string

Iris Z Jaffe

http://www.w3.org/2001/XMLSchema#string

James R Sowers

http://www.w3.org/2001/XMLSchema#string

Shawn B Bender

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

A novel adipokine CTRP1 stimulates aldosterone production

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor

Mineralocorticoid receptor antagonists and endothelial function

Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1

Insulin and insulin-like growth factor-I receptors differentially mediate insulin-stimulated adhesion molecule production by endothelial cells.

Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors

Aldosterone production and insulin resistance in healthy adults

Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability

P304

313-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB12-0905

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235371893

http://www.w3.org/2001/XMLSchema#string

P698

23349535

http://www.w3.org/2001/XMLSchema#string

P921

intracellular receptor

type-2 diabetes

diabetic angiopathy

maturity-onset diabetes of the young

P932

3554383

http://www.w3.org/2001/XMLSchema#string